解剖性肺段切除术治疗早期非小细胞肺癌的研究进展  

Research progress of anatomical segmentectomy in the treatment of early non-small cell lung cancer

作　　者：孙卓琛 黄云超[1] 赵光强[1] 李炫呈 李首卓 所元东 孟迪 SUN Zhuochen;HUANG Yunchao;ZHAO Guangqiang;LI Xuancheng;LI Shouzhuo;SUO Yuandong;MENG Di(The First Department of Thoracic Surgery,Yunnan Cancer Hospital,The Third Affiliated Hospital of Kunming Medical University,Kunming,650100,P.R.China)

机构地区：[1]昆明医科大学第三附属医院云南省肿瘤医院胸外一科,昆明650100

出　　处：《中国胸心血管外科临床杂志》2022年第10期1384-1389,共6页Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

基　　金：国家自然科学基金(81960335);国家重点研发计划“精准医学研究”重点专项(2017YFC0907902)。

摘　　要：肺癌作为全球范围内发病率和病死率增长最快的恶性肿瘤之一,已经对人们的健康造成了严重的影响。随着医疗技术的不断进步,越来越多的医学手段应用于肺癌筛查,使得早期肺癌的检出率逐渐增高。目前治疗早期非小细胞肺癌的标准术式仍是肺叶切除加纵隔淋巴结清扫术。随着对肺部解剖学、病理学、影像学等特征的深入研究,使用肺段切除术治疗早期肺癌的趋势越来越大。解剖性肺段切除术在最大限度切除病灶的同时,也最大限度地保留了肺功能,其优势也显而易见。本文对解剖性肺段切除术治疗早期非小细胞肺癌的进展进行综述。Lung cancer,as one of the malignant tumors with the fastest increasing morbidity and mortality in the world,has a serious impact on people’s health.With the continuous advancement of medical technology,more and more medical methods are applied to lung cancer screening,which has gradually increased the detection rate of early lung cancer.At present,the standard operation for the treatment of early non-small cell lung cancer(NSCLC)is still lobectomy and mediastinal lymph node dissection.There is a growing trend to use segmentectomy for the treatment of early stage lung cancer.Anatomical segmentectomy not only removes the lesions to the maximum extent,but also preserves the lung function to the greatest extent,and its advantages are also obvious.This article reviews the progress of anatomical segmentectomy in the treatment of early NSCLC.

关 键 词：肺结节 早期肺癌 解剖性肺段切除术 段间平面 综述 

分 类 号：R734.2[医药卫生—肿瘤]